Indication

Nosocomial pneumonia due to Klebsiella pneumoniae

Nosocomial pneumonia due to *Klebsiella pneumoniae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*, typically developing 48 hours or more following admission. Read more about Nosocomial pneumonia due to Klebsiella pneumoniae

50 drugs 46 manufacturers

Advertisement

Drugs that treat it

Common Nosocomial pneumonia due to Klebsiella pneumoniae therapies.

Showing 46–50 of 50 drugs

Filter & compare in the drug finder →Opens the drug finder with Nosocomial pneumonia due to Klebsiella pneumoniae preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Nosocomial pneumonia due to Klebsiella pneumoniae.

Nosocomial pneumonia due to *Klebsiella pneumoniae* is a hospital-acquired lower respiratory tract infection caused by the Gram-negative, encapsulated bacterium *Klebsiella pneumoniae*, typically developing 48 hours or more following admission.

It predominantly affects hospitalized individuals in intensive care units, mechanically ventilated patients, the elderly, and immunocompromised hosts with chronic underlying conditions.

Pathophysiologically, the organism colonizes the oropharynx or medical devices and is microaspirated into the lower respiratory tract, where virulence determinants—such as a thick polysaccharide capsule and endotoxins—promote parenchymal inflammation, extensive tissue necrosis, and purulent alveolar exudation.

Clinically, it manifests with fever, productive cough with purulent sputum, dyspnea, leukocytosis, and focal pulmonary infiltrates on imaging, frequently complicated by cavitation, abscess formation, or multidrug resistance.

Personalize your experience

Follow Nosocomial pneumonia due to Klebsiella pneumoniae and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it